Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
11h
Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 PatientsSHIELD II Enrolled more than ...
US companies are putting up one of their best earnings seasons in three years on the back of robust economic growth. It’s ...
Lincoln Financial Field is going to look slightly different at the start of the Philadelphia Eagles‘ next season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback